Navigation Links
ZONARE Introduces L20-5 High Frequency Ultrasound Transducer at RSNA

Chicago, IL (PRWEB) December 02, 2013

ZONARE, a leading developer of new generation ultrasound technology, will introduce the new L20-5 ultrasound transducer at the annual Radiology Society of North America (RSNA) being held in Chicago, December 1 – 5, 2013. This breakthrough transducer, based on ZONE Sonography™ Technology (ZST), has unsurpassed image resolution for a wide variety of clinical applications.

“The L20-5 is continuously focused on both transmit and receive,” said Glen Mclaughlin, PhD, chief technology officer and founder of ZONARE. “Based on next generation ZST, this new light weight, ergonomically designed transducer provides motion compensated persistence to maintain image crispness in a dynamic environment. The superb resolution of this versatile probe provides an optimally focused image from the first millimeter to the last enabling new performance levels.”

The L20-5 transducer has a 32 millimeter aperture and up to five centimeter penetration. It supports B-Mode, compounded harmonics, spatial compounded harmonics CD-Mode, PDI, dPDI, PW-Mode, HPRF, M-Mode, elastography and CEUS. It provides excellent imaging for pediatric, musculoskeletal, breast, testicle, interventional, vascular, contrast enhanced ultrasound (CEUS), advanced research and other applications.

ZST is an innovative approach to echo data acquisition and image formation. Using a small number of large “zones,” ZST acquires ultrasound data up to ten times faster than conventional ultrasound and extracts more information on each transmit receive cycle. Since the speed of sound traveling through tissue is a physical constant, ZST has a significantly faster acoustic acquisition time enabling superior imaging quality.

ZST is a Living Technology which delivers ultrasound imaging excellence based on a dynamic and open architecture that allows continual platform evolvement. To this end, the company is also showcasing a significant new upgrade for its ZS3 ultrasound platform.

“The upgrade provides a number of additional enhancements, transducers and clinical options,” said Mclaughlin. “For example, there are several cardiology and advanced vascular options. It also enables CEUS imaging for SonoVue GI and Definity cardiac contrast agents.”

The Cardiac Option provides cardiac calculations, CW imaging on several transducers, auxiliary CW, ECG and respiratory functions. Imaging enhancements include B-mode imaging with improved spatial and contrast resolution as well as better needle visualization and image uniformity. New transducers are the C8-3 3D, E9-3 3D/4D, P8-3 TEE multi-plane and the enablement of 5 MHz and 2MHz Aux CW transducers.


ZONARE is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and Zone Sonography ™ Technology (ZST) architecture of the ultra and ZS3 platforms deliver high-end image quality and clinical versatility. ZONARE is now an independently run, wholly owned subsidiary of Mindray Medical International. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UrgentRad Teleradiology, LLC (UrgentRad) Introduces Services in California Urgent Care Market
2. Supreme Skin in Asehville, NC Introduces New Treatments That Sculpt and Contour The Face and Body, Much Like Exercise Does
3. Smart Fog, Inc. Introduces Ultra Clean Commercial Humidifier for the Pharmaceutical Industry
4. Dr. Ellis List, Cosmetic Dentist in Durham, NC Introduces Permanent Solution for Missing Teeth
5. Hair Transplant Surgeon Dr. Parsa Mohebi Introduces a Complete Guide to Modern Hair Restoration
6. Foot Levelers Introduces Dr. Jon Mulholland as Seminar Speaker
7. Introduces Its New CNC Lathe PEEK Products
8. Dentilo Introduces Practice Identity Kits for Dentists Starting from $250
9. Casket Company Introduces Its Metal Caskets For The USA Market
10. HeartMath® Introduces the HeartCloud™ – a new platform developed for all HeartMath technology products
11. Med Transport Center Introduces a $500 Holiday Gift Certificate on 4 Long Distance Medical Transportation Services
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: